BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30605956)

  • 21. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT; Lau YK; Wong KS; Chiang GS
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.
    Brakemeier S; Bachmann F; Budde K
    Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Use-Long-term Follow-up of First Tuberous Sclerosis Complex Patient Treated De Novo With Sirolimus After Kidney Transplantation: A Case Report.
    Tarasewicz A; Dębska-Ślizień A; Rutkowska B; Szurowska E; Matuszewski M
    Transplant Proc; 2018; 50(6):1904-1909. PubMed ID: 30056926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOL1 channel blocker reduces proteinuria in FSGS.
    Olabisi OA
    Kidney Int; 2023 Aug; 104(2):228-230. PubMed ID: 37224918
    [No Abstract]   [Full Text] [Related]  

  • 26. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK; Yan HD; Hewitson TD; Nicholls KM; Fairley KF; Kincaid-Smith P; Becker GJ
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.
    Schwartz RA; Fernández G; Kotulska K; Jóźwiak S
    J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R; Wu W; Wen Y; Li X
    Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiomyolipomas, renal manifestation of tuberous sclerosis complex in 17-year-old boy--a case report.
    Brodkiewicz A; Marciniak H; Szychot E; Walecka A; Peregud-Pogorzelski J
    Ann Acad Med Stetin; 2008; 54(2):160-5. PubMed ID: 19374247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus for Retinal Astrocytic Hamartoma Associated with Tuberous Sclerosis Complex.
    Zhang ZQ; Shen C; Long Q; Yang ZK; Dai RP; Wang J; Zhang W; Pan Q; Zhu Z; Xu KF
    Ophthalmology; 2015 Sep; 122(9):1947-9. PubMed ID: 25912145
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
    Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
    Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
    Lee YJ; Cho S; Kim SR; Jang HR; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Postgrad Med J; 2011 Oct; 87(1032):664-9. PubMed ID: 21715572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nephrotic syndrome in a woman with tuberous sclerosis].
    Sauter M; Berger F; Fischereder M
    Dtsch Med Wochenschr; 2014 May; 139(20):1046-50. PubMed ID: 24801299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
    Sener S; Sasmaz S
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
    Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
    Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.
    Yilmaz MI; Korkmaz A; Kaya A; Sonmez A; Caglar K; Topal T; Eyileten T; Yenicesu M; Acikel C; Oter S; Yaman H; Aktug H; Oguz Y; Vural A; Ikizler TA
    Nephron Exp Nephrol; 2006; 104(1):e15-22. PubMed ID: 16699289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
    Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
    Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ominous sequence in patients with tuberous sclerosis complex.
    Yamada H; Akiyoshi K; Izumi T
    Brain Dev; 2014 Mar; 36(3):254-8. PubMed ID: 23647917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
    Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.